GSK Says Drugs from Closed Plant Safe

Drugs produced at a GlaxoSmithKline pharmaceutical plant in North Carolina closed earlier this week are safe, the company said, adding that production is due to restart by the beginning of next week.

The plant at Zebulon east of Raleigh manufactures inhaled medications. It was closed after routine testing found Legionella bacteria in two external cooling towers. "No employees are sick and no products have been compromised," a GSK spokesperson said. "Medicines were not exposed to the bacteria."

North Carolina health officials said no cases of Legionnaires' disease linked to the Glaxo plant have been reported. But GSK said the building was closed because the cooling towers maintain temperature and humidity needed for manufacturing and working conditions.

The US Food and Drug Administration was still looking into the incident on Thursday.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.